HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.

[1]  D. Gjertson,et al.  Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans , 2006, Immunogenetics.

[2]  A. Toubert,et al.  Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders , 2006, Bone Marrow Transplantation.

[3]  F. Christiansen,et al.  KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  A. Gratwohl,et al.  Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland , 2006, Bone Marrow Transplantation.

[5]  C. Carcassi,et al.  Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction. , 2006, Blood.

[6]  N. Russell,et al.  HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. , 2006, Blood.

[7]  J. Partanen,et al.  Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Réunion. , 2005, Tissue antigens.

[8]  M. Horowitz,et al.  Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. , 2005, Blood.

[9]  Effie W Petersdorf,et al.  Limits of HLA mismatching in unrelated hematopoietic cell transplantation. , 2004, Blood.

[10]  Harriet Noreen,et al.  Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. , 2004, Blood.

[11]  Marcos González,et al.  HLA-DPB1 MISMATCH IN HLA-A-B-DRB1 IDENTICAL SIBLING DONOR STEM CELL TRANSPLANTATION AND ACUTE GRAFT-VERSUS-HOST DISEASE , 2004, Transplantation.

[12]  R. Handgretinger,et al.  Determinants of Antileukemia Effects of Allogeneic NK Cells 1 , 2004, The Journal of Immunology.

[13]  Maria Pia Sormani,et al.  A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. , 2003, Blood.

[14]  J. Cazenave,et al.  Mono-allelic amplification of exons 2-4 using allele group-specific primers for sequence-based typing (SBT) of the HLA-A, -B and -C genes: preparation and validation of ready-to-use pre-SBT mini-kits. , 2003, Tissue antigens.

[15]  James McCluskey,et al.  A Naturally Selected Dimorphism within the HLA-B44 Supertype Alters Class I Structure, Peptide Repertoire, and T Cell Recognition , 2003, The Journal of experimental medicine.

[16]  Franco Locatelli,et al.  Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. , 2003, Blood.

[17]  J. Madrigal,et al.  The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation , 2003, Bone Marrow Transplantation.

[18]  K. Hsu,et al.  The killer cell immunoglobulin‐like receptor (KIR) genomic region: gene‐order, haplotypes and allelic polymorphism , 2002, Immunological reviews.

[19]  R. Tamouza,et al.  DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation , 2002, Bone Marrow Transplantation.

[20]  H. Inoko,et al.  The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. , 2002, Blood.

[21]  E Lanino,et al.  Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. , 2001, Blood.

[22]  A. Tosti,et al.  Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. , 1999, Blood.

[23]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[24]  J. McCluskey,et al.  Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation. , 1999, Human immunology.

[25]  Takato O. Yoshida,et al.  EFFECT OF MATCHING OF CLASS I HLA ALLELES ON CLINICAL OUTCOME AFTER TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS FROM AN UNRELATED DONOR , 1998 .

[26]  G. Longton,et al.  Definition of HLA-DQ as a transplantation antigen. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.